AL
GILD icon

Agran Libbie’s Gilead Sciences GILD Stock Holding History

Agran Libbie’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$6.24M Sell
91,825
-1,370
-1% -$96.3K 1.47% 29
2016
Q4 		$6.67M Sell
93,195
-669
-0.7% -$49.7K 1.62% 24
2016
Q3 		$7.43M Buy
93,864
+106
+0.1% +$8.61K 2.12% 19
2016
Q2 		$7.82M Buy
93,758
+1,386
+2% +$123K 1.95% 19
2016
Q1 		$8.48M Buy
92,372
+2,356
+3% +$212K 2.17% 12
2015
Q4 		$9.11M Buy
90,016
+1,333
+2% +$139K 2.4% 9
2015
Q3 		$8.71M Buy
88,683
+1,880
+2% +$209K 2.43% 10
2015
Q2 		$10.2M Sell
86,803
-2,914
-3% -$318K 2.64% 6
2015
Q1 		$8.8M Sell
89,717
-130
-0.1% -$13.2K 2.1% 15
2014
Q4 		$8.47M Buy
89,847
+86
+0.1% +$8.89K 2.02% 18
2014
Q3 		$9.55M Sell
89,761
-1,215
-1% -$119K 2.34% 9
2014
Q2 		$7.54M Sell
90,976
-299
-0.3% -$23.3K 1.93% 19
2014
Q1 		$6.47M Sell
91,275
-5,136
-5% -$403K 1.74% 21
2013
Q4 		$7.24M Sell
96,411
-3,372
-3% -$235K 1.91% 18
2013
Q3 		$6.27M Sell
99,783
-1,275
-1% -$76.2K 1.82% 20
2013
Q2 		$5.18M Buy
+101,058
New +$5.27M 1.5% 26

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Agran Libbie's GILD Position: Q1 2017 in Review

Agran Libbie reduced its Gilead Sciences (GILD) stake by 1.5% in Q1 2017, selling an estimated $96.3K and leaving 91,825 shares worth $6.24M. The position accounts for 1.47% of the portfolio, ranked #29.

Agran Libbie first reported a position in GILD in Q2 2013 and has held it in 16 quarters since. The position peaked at $10.2M in Q2 2015. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Agran Libbie held 91,825 shares of Gilead Sciences worth $6.24M as of Q1 2017.
  • Agran Libbie sold 1,370 Gilead Sciences shares in Q1 2017, an estimated $96.3K.
  • Gilead Sciences made up 1.47% of Agran Libbie's portfolio in Q1 2017, its #29 holding.
  • Agran Libbie first reported a position in Gilead Sciences in Q2 2013 and has held it in 16 quarters since.
  • Agran Libbie's Gilead Sciences position peaked at $10.2M in Q2 2015.
  • 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Agran Libbie's 13F filing for Q1 2017, filed 27 Apr 2017.